-
Uncategorized1 month agoSupreme Court extends mifepristone deadline
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. My co-workers and pals Isabella Cueto...
-
Uncategorized1 month ago
Kyverna begins rolling submission for autoimmune CAR-T as FDA requests more natural history analysis
Kyverna Therapeutics has officially started a rolling submission to the FDA for miv-cel as the company conducts additional natural history analysis at the agency’s request, keeping...
-
Uncategorized1 month ago
Five burning Qs for Isomorphic Labs after $2.1B raise for AI biotech
Five burning Qs for Isomorphic Labs after $2.1B raise for AI biotech
-
Uncategorized1 month ago
Pfizer and Arvinas give disappointing breast cancer drug to Rigel
Pfizer has turned $1 billion into $35 million. The New York-based pharma company and its partner Arvinas are selling rights to their recently approved breast cancer...
-
Uncategorized1 month agoSTAT+: STAT examines America’s deadliest drug
“Under-babied.” Dr. Oz said that’s the name for a condition that affects one-in-three Americans. I guess that means over-babied is the condition of having too many...
-
Uncategorized1 month ago
Bayer to make ‘careful but aggressive’ return to pharma M&A, CEO says
Bayer is back on the market for drug acquisitions after a half-decade on the sidelines, according to CEO Bill Anderson. “We’re going to be careful, but...
-
Uncategorized1 month ago
Biotech’s IPO tide is finally turning, thanks in part to the recent M&A surge
After years of suffering from a bear market and more than 14 months of geopolitical turmoil shaking the macroenvironment, biotech appears to be moving on.
-
Uncategorized1 month agoIntroducing Benchling Biologics: AI infrastructure for modern drug discovery (Americas Session)
Antibody discovery is being reshaped by two forces: an explosion of novel formats and the growing role of AI across the DBTL loop. But most teams...
-
Uncategorized1 month ago
Knit Health raises $11.6M for ‘fundamentally different’ approach to healthcare AI
A startup that spun out of UC Berkeley aims to improve healthcare operations by getting AI to think like a doctor would. Knit Health launched with...
-
Uncategorized1 month ago
BMS, Hengrui build 13-asset pipeline in $15B+ onco-immune deal
Of the 13 programs that the companies will advance, four will come from Hengrui Pharma and four from Bristol Myers Squibb. The remaining five assets will...
Hantavirus One-Shot mRNA Vaccine Fully Protects in Syrian Hamster Model
SonoThera Raises $125M to Develop Ultrasound-Mediated Genetic Medicines
